2-Pyrrolidinecarboxamide, with the specified structure and CAS number 3031995-12-4, is a complex organic compound characterized by its pyrrolidine ring and various functional groups, including a carboxamide and a hydroxy group. This compound features a stereocenter, indicating chirality, which can influence its biological activity and interactions. The presence of an isoxazole moiety suggests potential applications in medicinal chemistry, as isoxazoles are often associated with pharmacological properties. Additionally, the thiazole and phenyl groups contribute to the compound's lipophilicity and may enhance its binding affinity to biological targets. The overall molecular structure indicates that it may exhibit specific conformational properties, which can affect its solubility, stability, and reactivity. Such compounds are typically investigated for their potential therapeutic applications, particularly in areas like neuropharmacology or anti-inflammatory research, due to their diverse functional groups and structural complexity. Further studies would be necessary to elucidate its precise biological activity and potential uses in drug development.

2-Pyrrolidinecarboxamide, 1-[(2R)-2-(2,3-dihydro-3-oxo-5-isoxazolyl)-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (2S,4R)-

3031995-12-4: 2-Pyrrolidinecarboxamide, with the specified structure and CAS number 3031995-12-4, is a complex organic compound characterized by its pyrrolidine ring and various functional groups, including a carboxamide and a hydroxy group. This compound features a stereocenter, indicating chirality, which can influence its biological activity and interactions. The presence of an isoxazole moiety suggests potential applications in medicinal chemistry, as isoxazoles are often associated with pharmacological properties. Additionally, the thiazole and phenyl groups contribute to the compound's lipophilicity and may enhance its binding affinity to biological targets. The overall molecular structure indicates that it may exhibit specific conformational properties, which can affect its solubility, stability, and reactivity. Such compounds are typically investigated for their potential therapeutic applications, particularly in areas like neuropharmacology or anti-inflammatory research, due to their diverse functional groups and structural complexity. Further studies would be necessary to elucidate its precise biological activity and potential uses in drug development.

E3 ligase Ligand 36 is an E3 ligase ligand that can be utilized for synthesizing PROTACs, such as PROTAC BRM/BRG1 degrader-1.

CAS 3031995-12-4

2-Pyrrolidinecarboxamide, 1-[(2R)-2-(2,3-dihydro-3-oxo-5-isoxazolyl)-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (2S,4R)-

E3 ligase Ligand 36

Ref: TM-T201850